INTRA-PATIENT DOSE-ESCALATION STUDY OF CRENOLANIB MAINTENANCE THERAPY IN PATIENTS WITH FLT3 MUTANT AML WHO HAD UNDERGONE ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT (ALLO-HSCT)

EHA Library, Betul Oran, 215319

CONSOLIDATION THERAPY WITH PONATINIB IN COMBINATION WITH CYTARABINE IN PATIENTS FOR FLT3-ITD ACUTE MYELOID LEUKEMIA IN FIRST COMPLETE REMISSION.

EHA Library, Philippe Rousselot, 215320

PHASE 1/1B STUDY OF PEVONEDISTAT (PEV) AS A SINGLE AGENT OR COMBINED WITH AZACITIDINE (AZA) IN EAST ASIAN PATIENTS (PTS) WITH ACUTE MYELOID LEUKEMIA (AML) OR MYELODYSPLASTIC SYNDROME (MDS)

EHA Library, SHANG-JU WU, 215321

ANALYSIS OF PHASE I AND PILOT PHASE II DATA REVEAL 2,000 MG/M2 AS THE OPTIMAL DOSE OF CPI-613 IN COMBINATION WITH CYTARABINE AND MITOXANTRONE FOR ELDERLY PATIENTS WITH RELAPSED OR REFRACTORY AML

EHA Library, Timothy Pardee, 215322

CLADRIBINE ADDED TO STANDARD INDUCTION CHEMOTHERAPY FOR ACUTE MYELOID LEUKAEMIA, 4-YEAR EXPERIENCES FROM SLOVENIA

EHA Library, Saša Anžej Doma, 215323

DECITABINE AS SINGLE AGENT FOR TREATMENT OF NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (AML) IN ELDERLY PATIENTS: A RETROSPECTIVE, MULTICENTER REAL LIFE STUDY OF THE “RETE EMATOLOGICA PUGLIESE” (REP)

EHA Library, Maria Pia Loglisci, 215324

FLUDARABINE, HIGH DOSE CYTARABINE AND IDARUBICIN-BASED INDUCTION (FLAI) IS HIGHLY EFFECTIVE IN AML WITH MUTATED NPM1 WITH CONCOMITANT FLT3-ITD MUTATION IRRESPECTIVELY OF FLT3-ITD ALLELIC BURDEN

EHA Library, Paola Minetto, 215325

CLINICAL CHARACTERISTICS AND PROGNOSIS OF 34 CASES OF ACUTE MYELOID LEUKEMIA WITH FLT3 INTERNAL TANDEM DUPLICATION AND MLL GENE REARRANGEMENT

EHA Library, Jian Ouyang, 215326

PROGNOSTIC RELEVANCE OF FLT3, NPM1, DNMT3A, IDH1/2 GENE MUTATIONS IN ACUTE MYELOID LEUKEMIA PATIENTS

EHA Library, Irina Martynkevich, 215327

IMPACT OF BCL2 AND ABCG2 OVEREXPRESSION IN ACUTE MYELOID LEUKEMIA

EHA Library, Mario Tiribelli, 215328

ABSOLUTE LYMPHOCYTE COUNT RECOVERY AFTER INDUCTION REMISSION THERAPY IS A STRONG PREDICTOR OF OVERALL SURVIVAL IN ADULT ACUTE MYELOID LEUKAEMIA

EHA Library, Joana Infante, 215329

TYROSINE KINASE INHIBITORS (TKI) IN RELAPSED/REFRACTORY (RR) PATIENTS WITH FLT3-ITD POSITIVE ACUTE MYELOID LEUKEMIA (AML) CONFER BETTER SURVIVAL THAN CHEMOTHERAPY, DUE TO A BETTER SAFETY PROFILE.

EHA Library, Giovanni Marconi, 215330

ADDITION OF BORTEZOMIB TO AML-LIKE TREATMENT FOLLOWED BY NMA ALLO-SCT IN PATIENTS WITH BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM

EHA Library, Elisabeth Tolley, 215331

BLAST TRANSFORMATION IN MYELODYSPLASTIC AND MYELOPROLIFERATIVE NEOPLASMS - SIMILARITIES AND DIFFERENCES - A REVIEW OF 100 CASES

EHA Library, Milan Jagurinoski, 215332

QUALITY OF LIFE IN ACUTE LEUKEMIA PATIENTS WITH COMORBID ISCHEMIC HEART DISEASE

EHA Library, Tetiana Lymanets, 215333

BIOMARKER ANALYSIS OF TISAGENLECLEUCEL PRE-INFUSION BIOPSIES OF ADULT PATIENTS WITH RELAPSED OR REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)

EHA Library, Ulrich Jäger, 215334

ACALABRUTINIB IN COMBINATION WITH THE PI3Kδ INHIBITOR ACP-319 IN PATIENTS WITH RELAPSED/REFRACTORY B-CELL MALIGNANCIES.

EHA Library, Paul M. Barr, 215335

TIME TO RELAPSE OF MANTLE CELL LYMPHOMA AFTER INTENSIVE HIGH DOSE CYTARABINE CONTAINING REGIMENS DEFINES PATIENTS RISK FOR DEATH: AN ANALYSIS FROM CENTERS OF THE FONDAZIONE ITALIANA LINFOMI

EHA Library, Carlo Visco, 215336

CC-122-DLBCL-001: PHASE IB STUDY OF CC-122 PLUS RITUXIMAB IN PATIENTS WITH CHEMO-REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Vincent Ribrag, 215337

EXTRACELLULAR CIRCULATING DNA IN DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS: BIOLOGICAL CORRELATES AND PROGNOSTIC IMPACT

EHA Library, Dino Dujmovic, 215338

ACALABRUTINIB MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) IN THE PHASE 1B ACE-LY-002 STUDY

EHA Library, Martin J. S. Dyer, 215339

OUTCOME OF PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) NOT ELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT)

EHA Library, Robert Pytlik, 215340

WOMEN WITH DIFFUSE LARGE B CELL LYMPHOMA BENEFIT MORE FROM RITUXIMAB-CONTAINING CHEMOTHERAPY

EHA Library, Huai-Hsuan Huang, 215341

RITUXIMAB, BENDAMUSTINE AND CYTARABINE (R-BAC) IN PATIENTS WITH RELAPSED-REFRACTORY AGGRESSIVE B- CELL LYMPHOMA

EHA Library, Maria Chiara Tisi, 215342

A PROPENSITY SCORE ANALYSIS SHOWS THAT RITUXIMAB DOSE-ADJUSTED EPOCH IMPROVES PROGRESSION-FREE SURVIVAL OF YOUNG PATIENTS AFFECTED BY DOUBLE EXPRESSOR DIFFUSE LARGE B -CELL LYMPHOMAS

EHA Library, Anna Guidetti, 215343

GENETIC EVIDENCE IMPLYING THE COMMON PRECURSOR CELLS FOR PRIMARY AND EXTRA-CENTRAL NERVOUS SYSTEM RELAPSED TUMORS IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA

EHA Library, Keiichiro Hattori, 215344

REAL-TIME CELL-OF-ORIGIN SUBTYPE IDENTIFICATION BY GENE EXPRESSION PROFILING IN PATIENTS WITH ABC-TYPE DLBCL IN THE PHASE III TRIAL OF LENALIDOMIDE + R-CHOP (R2-CHOP) VS PLACEBO + R-CHOP (ROBUST)

EHA Library, Annalisa Chiappella, 215345

EXCELLENT OUTCOMES OF OLDER PATIENTS WITH PCNSL USING R-MPV/ARA-C IMMUNOCHEMOTHERAPY WITHOUT WHOLE BRAIN RADIOTHERAPY (WBRT)

EHA Library, Gareth Gregory, 215346

FIRST REPORT ON A SUCCESSFUL SCREENING PROGRAM FOR MYC REARRANGEMENTS AND A PROSPECTIVE CLINICAL TRIAL BASED ON MYC REARRANGEMENT IN NEWLY DIAGNOSED DLBCL PATIENTS IN THE NETHERLANDS

EHA Library, Martine Chamuleau, 215347

A NOVEL IMMUNOHISTOCHEMICAL PROGNOSTIC SCORE BASED ON MYC, BCL2 AND BCL6 EXPRESSION IN DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL): RETROSPECTIVE ANALYSIS OF DE NOVO DLBCL TREATED WITH RITUXIMAB-CHOP

EHA Library, Mattia Novo, 215348

ASSESSMENT OF BONE MARROW INFILTRATION AND MINIMAL RESIDUAL DISEASE BY MULTIDIMENSIONAL FLOW CYTOMETRY IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, M Baile, 215349

ON THE APPLICABILITY OF RHOA GLY17VAL POINT MUTATION TESTING FOR A DIFFERENTIAL DIAGNOSIS OF ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA

EHA Library, Yulia Sidorova, 215350

THE ADDITION OF ROMIDEPSIN TO CHOEP FOLLOWED BY HIGH-DOSE CHEMOTHERAPY AND TRANSPLANTATION IS FEASIBLE IN UNTREATED PERIPHERAL T-CELL LYMPHOMAS: RESULTS OF PHASE IB FIL-PTCL13

EHA Library, Annalisa Chiappella, 215351

A PHASE I, MULTICENTER, OPEN-LABEL DOSE-ESCALATION STUDY OF CC-122, A NOVEL CEREBLON-MODULATING AGENT, IN ADULT JAPANESE PATIENTS WITH ADVANCED NON-HODGKIN LYMPHOMA OR SOLID TUMOR

EHA Library, Kazuhito Yamamoto, 215352

GLOBAL LONGITUDINAL STRAIN (2D-GLS) IN LYMPHOMA PATIENTS TREATED WITH CHEMOTHERAPY +/- MEDIASTINAL RADIOTHERAPY: EARLY SUBCLINICAL CARDIOTOXICITY IN THE CARDIOCARE PROSPECTIVE OBSERVATIONAL STUDY.

EHA Library, Barbara Botto, 215353

CLINICAL FEATURES, TREATMENT AND PROGNOSTIC FACTORS FOR EXTRANODAL NATURAL KILLER/T-CELL LYMPHOMA, NASAL TYPE, IN THE SPANISH POPULATION. A STUDY FROM THE SPANISH GROUP GELTAMO.

EHA Library, EVA GONZALEZ BARCA, 215354

ARE OUTCOMES IMPROVING IN POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER? A RETROSPECTIVE ANALYSIS OF THE LAST 10 YEARS

EHA Library, Nicholas Denny, 215355

PHASE II STUDY WITH OBINUTUZUMAB-DHAP IN RELAPSED/REFRACTORY DLBCL PATIENTS BEFORE AUTOLOGOUS STEM CELL TRANSPLANTATION: A STUDY FROM THE FONDAZIONE ITALIANA LINFOMI (GIOTTO STUDY)

EHA Library, Luigi Rigacci, 215356

COMPARISON OF R-CHOP, R-CVP, CHOP, AND CVP FOR PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA IN TAIWAN: A POPULATION-BASED STUDY, 2009-2013

EHA Library, Huai-Hsuan Huang, 215357

HIGH INCIDENCE OF CARDIOMYOPATHY IN PATIENTS RECEIVING CHOEP14 - POSSIBLE SYNERGISTIC CARDIOTOXICITY OF DOSE-DENSE DOXORUBICIN AND ETOPOSIDE

EHA Library, Igor Aurer, 215358

PROGNOSTIC IMPACT OF SITES OF EXTRANODAL INVOLVEMENT IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA IN THE RITUXIMAB ERA

EHA Library, Norihito Inoue, 215359

LIPOSOMAL DOXORUBICIN IN AGGRESSIVE B CELL LYMPHOMA SHOWS SIMILAR EFFICACY TO THE CONVENTIONAL FORMULATION: LONG TERM RESULTS FROM A RETROSPECTIVE COHORT STUDY

EHA Library, Ana García-Noblejas, 215360

CLINICAL CHARACTERISTICS AND PROGNOSTIC FACTORS OF HEMOPHAGOCYTIC SYNDROME IN ADULT PATIENTS: A RETROSPECTIVE SINGLE-CENTER STUDY FROM SINGAPORE

EHA Library, Shin-Yeu ONG, 215361

THE IMPACT OF DIFFERENT IMMUNOCHEMOTHERAPY REGIMENS ON SURVIVAL OUTCOMES IN 131 NEWLY DIAGNOSED PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA

EHA Library, Gayane Tumyan, 215362

TREATMENT OF TRAUMATIC BLEEDS WITH RECOMBINANT FACTOR XIII-A2 IN PATIENTS WITH CONGENITAL FXIII-A SUBUNIT DEFICIENCY: RESULTS FROM THE MENTOR™6 STUDY

EHA Library, Jolanta Klovaite, 215363

BEVACIZUMAB SIGNIFICANTLY IMPROVES SEVERE EPISTAXIS IN HEREDITARY HEMORRHAGIC TELANGIECTASIA

EHA Library, Silva Zupancic salek, 215364

AN AUDIT OF THE USE OF PROTHROMBIN COMPLEX CONCENTRATION

EHA Library, Samantha Bonney, 215365

HAEMOSTATIC ABNORMALITIES OR DEFECTS IN GREEK PATIENTS WITH GAUCHER DISEASE

EHA Library, Veroniki Komninaka, 215366

THALIDOMIDE USE IN HEREDITARY HEMORRHAGIC TELANGIECTASIA: A RETROSPECTIVE EVALUATION OF THE PATIENTS

EHA Library, Mehmet Baysal, 215367

DIAGNOSIS AND MANAGEMENT OF ACQUIRED VON WILLEBRAND DISEASE. A SINGLE CENTER EXPERIENCE

EHA Library, Cristina Santoro, 215368

CONGENITAL FXIII DEFICIENCY IN PAKISTAN

EHA Library, Munira Borhany, 215369

DISSEMINATED INTRAVASCULAR COAGULATION SCORING IN CHILDREN WITH ACUTE LEUKEMIA: IS THERE A SIMPLER AND ECONOMICAL ALTERNATIVE?

EHA Library, Yasmine El Chazli, 215370

EFFECT OF THROMBOELASTOGRAPHY DEFINED COAGULOPATHY IN TRAUMATIC BRAIN INJURY

EHA Library, DIBYENDU DE, 215371

ASSESSMENT AT DIAGNOSIS OF 200 PATIENTS WITH A PNH CLONE OR GPI-DEFICIENT CELLS ≥0.01% ENROLLED IN A NATION-WIDE MULTICENTRIC PROSPECTIVE OBSERVATIONAL STUDY

EHA Library, Orianne Wagner-Ballon, 215372

ASSOCIATION OF AUTOPHAGY-RELATED GENE 5 VARIANTS WITH ACQUIRED APLASTIC ANEMIA IN HAN-CHINESE POPULATION

EHA Library, Yahong You, 215373

PHASE IB STUDY OF THE CXCR4 ANTAGONIST BL8040 COMBINED WITH IMMUNOSUPPRESSIVE THERAPY IN PATIENTS WITH APLASTIC ANEMIA

EHA Library, Tapan Kadia, 215374

CLINICAL EFFICACY OF THERAPIES FOR TRANSFUSION-DEPENDENT NON-SEVERE APLASTIC ANEMIA: A RETROSPECTIVE COHORT STUDY IN MULTIPLE HOSPITALS

EHA Library, Guangsheng He, 215375

IDIOPATHIC NEUTROPENIA OF INFANCY: DATA FROM THE ITALIAN NEUTROPENIA REGISTRY

EHA Library, Piero Farruggia, 215376

DYNAMICS OF CMV AND EBV LOADS AFTER IMMUNOSUPPRESSIVE TREATMENT WITH RABBIT ATG AND CYCLOSPORINE IN ADULT APLASTIC ANEMIA: A PROSPECTIVE OBSERVATIONAL STUDY

EHA Library, Jong Wook Lee, 215377

PHASE 2 STUDY OF X4P-001: A TARGETED ORAL THERAPY FOR PATIENTS WITH WHIM SYNDROME

EHA Library, David Dale, 215378

SCREENING FOR TELOMERE DISEASE IS IMPORTANT TO IMPROVE THE OUTCOME OF HSCT IN PEDIATRIC PATIENTS SUFFERING FROM SEVERE APLASTIC ANEMIA.

EHA Library, Iris Nederlof, 215379

RESULTS OF HEMATOPOIETIC STEM CELLS TRANSPLANTATION IN CONGENITAL BONE MARROW FAILURE SYNDROMES: SINGLE CENTER EXPERIENCE WITH FOCUS ON TCR ΑΒ+/CD19+ DEPLETION

EHA Library, Zhanna Shekhovtsova, 215380

REACTIVATION OF HEPATITIS B VIRUS INFECTION IN APLASTIC ANEMIA PATIENTS RECEIVING IMMUNOSUPPRESSIVE THERAPY

EHA Library, Guangsheng He, 215381

ADULT PATIENTS WITH ACQUIRED PURE RED CELL APLASIA: COMBINATION OF CYCLOSPORINE A AND CORTICOSTEROIDS PRODUCE BETTER CR

EHA Library, Guangsheng He, 215382

MANAGEMENT OF PATIENTS WITH SEVERE APLASTIC ANAEMIA WHO ARE REFRACTORY TO PLATELET TRANSFUSIONS USING LEUKOCYTE CONCENTRATES

EHA Library, jiali Huo, 215383

IRON OVERLOAD AND MANAGEMENT IN PATIENTS WITH DIAMOND BLACKFAN ANEMIA

EHA Library, Sule Unal, 215384

HIGHER RATE OF DYSMORPHIC FEATURES IN PATIENTS WITH DIAMOND BLACKFAN ANEMIA

EHA Library, Sule Unal, 215385

OPTIMIZING MRD RESPONSE ASSESSMENT USING HIGH-SENSITIVITY PERIPHERAL BLOOD MONITORING DURING TREATMENT WITH IBRUTINIB COMBINED WITH OBINUTUZUMAB OR VENETOCLAX IN CLL .

EHA Library, Andy C. Rawstron, 215386

DYNAMIC OF TELOMERIC PARAMETERS IN RELAPSING OR REFRACTORY (R/R) CHRONIC LYMPHOCYTIC LEUKEMIA (CLL), AN ANALYSIS OF THE FILO ICLL001 BOMP TRIAL

EHA Library, laura bounaix, 215387

HIGH CD9 EXPRESSION IS ASSOCIATED WITH THE MYD88 L265P MUTATION AND REDUCED FAILURE-FREE SURVIVAL IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Jennifer Brown, 215388

CERDULATINIB SYNERGISES WITH BCL-2 AND MCL-1 INHIBITORS TO INDUCE SUPERIOR CELL DEATH IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Andrew J. Steele, 215389

SELECTIVE CHK1 INHIBITOR MU380 EXHIBITS SINGLE-AGENT ACTIVITY AGAINST CHRONIC LYMPHOCYTIC LEUKEMIA CELLS WITH TP53 MUTATIONS

EHA Library, Miroslav Boudny, 215390

PI3K INHIBITORS INHIBIT TUMOR MICROENVIRONMENT (TME) REGULATION OF PROGRAMMED DEATH-1 (PD1) AND PDL1/2 IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): A POTENTIAL APPROACH TO OVERCOME TUMOR-INDUCED TOLERANCE

EHA Library, Fortunato Morabito, 215391

PEMBROLIZUMAB (PEM) ACTIVITY IN CLL IS IMMUNE TO TUMOR MICROENVIRONMENTAL (TME) STIMULI

EHA Library, Fortunato Morabito, 215392

DUAL MTOR KINASE INHIBITORS SYNERGIZE WITH IBRUTINIB TO INDUCE CLL APOPTOSIS, AND OVERCOME BCR- AND STROMAL-MEDIATED SURVIVAL ADVANTAGES CONFERRED IN THE MICROENVIRONMENT

EHA Library, Michael Moles, 215393

DEVELOPMENT OF SELECTIVE CASEIN KINASE 1 DELTA/EPSILON INHIBITORS FOR CANCER THERAPY

EHA Library, Michaela Gregorova, 215394

NEXT-GENERATION SEQUENCING AND CRISPR/CAS9 APPLICATION TO ELUCIDATE THE IMPLICATIONS OF TP53 MUTATIONS IN DEL(13Q) CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Miguel Quijada-Álamo, 215396

ENCYCLOPEDIA OF CLL SUBSETS: AN ONLINE KNOWLEDGEBASE FOR SUBSETS OF CLL CASES WITH STEREOTYPED B CELL RECEPTORS

EHA Library, Tomas Reigl, 215397

ANALYSIS OF LOCUS-SPECIFIC LINE-1 AND ALU ELEMENT DNA METHYLATION REVEALS NOVEL EARLY EPIGENETIC CHANGES IN CHRONIC LYMPHOCYTIC LEUKAEMIA

EHA Library, Timothy Barrow, 215398

ILT3/DELTEX-1/SHIP-1 AS A NOVEL INHIBITORY AXIS CONTROLLING B CELL RECEPTOR SIGNALING IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Anna KABANOVA, 215399

DETIN: OVERCOMING TUMOR IN NORMAL CONTAMINATION.

EHA Library, Amaro Taylor-Weiner, 215400

TRACKING THE MINOR CLONES IN OLIGOCLONAL CHRONIC LYMPHOCYTIC LEUKEMIA USING HIGH-THROUGHPUT IMMUNOPROFILING

EHA Library, Kamila Stranska, 215401

SINGLE CELL ABNORMALITIES ON CLASSIC G-BANDING ANALYSIS OF CHRONIC LYMPHOCYTIC LEUKEMIA: A NEW DIAGNOSTIC AND BIOLOGICAL CHALLENGE?

EHA Library, Anastasia Athanasiadou, 215402

HIGHER RESPONSIVENESS OF CLL CELLS TO B-CELL RECEPTOR STIMULATION IS ASSOCIATED WITH REDUCED EXPRESSION OF INHIBITORY MOLECULES OF THE NF-ΚB PATHWAY

EHA Library, Ruud Meijers, 215403

COMPARISON OF CELLULAR AND CELL-FREE DNA FOR THE DETECTION AND MONITORING OF BTK MUTATED CLL CLONES IN PATIENTS WITH SUBSEQUENT THERAPY AFTER IBRUTINIB FAILURE

EHA Library, Wiebke Schier, 215404

NOVEL STRATEGIES OF TARGETING P53 RELATED VULNERABILITIES IN T-PLL CELLS

EHA Library, Jana von Jan, 215405

HIGH SET ALPHA TO SET BETA ISOFORM EXPRESSION IS ASSOCIATED WITH INFERIOR OUTCOMES AND DISCRIMINATES FAVORABLE RISK IN TWO INDEPENDENT CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) COHORTS

EHA Library, Danielle M. Brander, 215406

NOTCH1 MUTATIONS ARE AN INDEPENDENT PROGNOSTIC FACTOR IN IBRUTINIB- TREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS

EHA Library, Giovanni DEL POETA, 215407

PROGNOSTIC IMPACT OF POSITIVE MINIMAL RESIDUAL DISEASE (MRD) BELOW THE THRESHOLD OF 0.01% IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS AFTER IMMUNOCHEMOTHERAPY: STUDY OF A DATASET FROM 3 FILO TRIALS

EHA Library, Remi Letestu, 215408

EVALUATION OF THE INCIDENCE, RISK FACTORS, AND MANAGEMENT OF HYPERTENSION IN PATIENTS RECEIVING IBRUTINIB FOR HEMATOLOGIC MALIGNANCIES

EHA Library, Farrukh Awan, 215409

EVALUATION OF THE CLL-IPI IN PREVIOUSLY UNTREATED CLL PATIENTS RECEIVING CHEMO-IMMUNOTHERAPY AS FIRST-LINE TREATMENT: ANALYSIS OF 845 CASES.

EHA Library, Massimo GENTILE, 215410

SPONTANEOUS CLINICAL REGRESSION IN CHRONIC LYMPHOCYTIC LEUKEMIA: CLINICAL AND BIOLOGIC FEATURES OF 27 NEW CASES FROM THE EUROPEAN RESEARCH INITIATIVE ON CLL (ERIC) INTERNATIONAL REGISTRY

EHA Library, Ilaria Del Giudice, 215411

A PROGNOSTIC TOOL FOR THE IDENTIFICATION OF EARLY STAGE CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS AT IMMINENT RISK OF PROGRESSION

EHA Library, Lodovico Terzi di Bergamo, 215412

SURVIVAL CONTINUES TO INCREASE IN CHRONIC LYMPHOCYTIC LEUKEMIA: A POPULATION-BASED ANALYSIS AMONG 19,131 PATIENTS DIAGNOSED IN THE NETHERLANDS BETWEEN 1989 AND 2015

EHA Library, Lina van der Straten, 215413

PROGNOSTICATION AND FIRST-LINE TREATMENT IN CHRONIC LYMPHOCYTIC LEUKEMIA: A CONTEMPORARY, NATIONWIDE, POPULATION-BASED ANALYSIS AMONG 1,677 PATIENTS DIAGNOSED IN THE NETHERLANDS

EHA Library, Lina van der Straten, 215414

“IMMUNO-FLOW-FISH”: HIGH THROUGHPUT FLUORESCENCE IN SITU HYBRIDISATION OF PHENOTYPED CHRONIC LYMPHOCYTIC LEUKAEMIA BY IMAGING FLOW CYTOMETRY FOR CLINICAL APPLICATION

EHA Library, Wendy Erber, 215415

EXPRESSION OF ANTIGENS INVOLVED IN THE FORMATION OF AN IMMUNOLOGICAL SYNAPSE IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Yulia Davydova, 215416

IDENTIFICATION OF NEWLY DIAGNOSED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA AT HIGH RISK OF INFECTION OR TREATMENT THROUGH MACHINE LEARNING ALGORITHMS

EHA Library, Carsten Niemann, 215417

HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN RELATION TO RESPONSE TO FIRSTLINE THERAPY AND SUBSEQUENT TREATMENTS – A METAANALYSIS OF HRQOL MEASURED IN PHASE III TRIALS OF THE GERMAN CLL STUDY GROUP

EHA Library, Nadine Kutsch, 215418

T-LARGE GRANULAR LYMPHOCYTIC (T-LGL) LEUKEMIA: A LONG-TERM STUDY ON 51 PATIENTS-COULD WE CONFINE THE USE OF THE TERM “LEUKEMIA”?

EHA Library, Xanthi Yiakoumis, 215419